Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nora B. Goren"'
Autor:
Azul V. Pieralisi, Ágata C. Cevey, Federico N. Penas, Nilda Prado, Ana Mori, Mónica Gili, Gerardo A. Mirkin, Juan Gagliardi, Nora B. Goren
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2022)
Chronic Chagas disease cardiomyopathy (CCC) is the most important clinical manifestation of infection with Trypanosma cruzi (T. cruzi) due to its frequency and effects on morbidity and mortality. Peripheral blood mononuclear cells (PBMC) infiltrate t
Externí odkaz:
https://doaj.org/article/b37c26a35ff94c1c822003ac05280bdf
Autor:
Ágata C. Cevey, Paula D. Mascolo, Federico N. Penas, Azul V. Pieralisi, Aldana S. Sequeyra, Gerardo A. Mirkin, Nora B. Goren
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Benznidazole (Bzl), the drug of choice in many countries for the treatment of Chagas disease, leads to parasite clearance in the early stages of infection and contributes to immunomodulation. In addition to its parasiticidal effect, Bzl inhibits the
Externí odkaz:
https://doaj.org/article/a448a705e0d847578212886c8a173008
Autor:
Jimena Rada, Martín Donato, Federico N. Penas, Catalina Alba Soto, Ágata C. Cevey, Azul V. Pieralisi, Ricardo Gelpi, Gerardo A. Mirkin, Nora B. Goren
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
IL-10 is an anti-inflammatory cytokine that plays a significant role in the modulation of the immune response in many pathological conditions, including infectious diseases. Infection with Trypanosoma cruzi (T. cruzi), the etiological agent of Chagas
Externí odkaz:
https://doaj.org/article/789a7dcbe9e04d4498aac08b8da6b2f8
Autor:
Ágata C. Cevey, Gerardo A. Mirkin, Martín Donato, María J. Rada, Federico N. Penas, Ricardo J. Gelpi, Nora B. Goren
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance, Vol 7, Iss 3, Pp 378-387 (2017)
Trypanosoma cruzi induces serious cardiac alterations during the chronic infection. Intense inflammatory response observed from the beginning of infection, is critical for the control of parasite proliferation and evolution of Chagas disease. Peroxis
Externí odkaz:
https://doaj.org/article/2098241fed4f460e822eb3c21cc598c1
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Anti-parasitic treatment for Chagas disease mainly relies on benznidazole, which is virtually the only drug available in the market. Besides its anti-parasitic effects, benznidazole has anti-inflammatory properties. In this work we studied the mechan
Externí odkaz:
https://doaj.org/article/5b549f72290a47658f292520769d03de
Publikováno v:
PPAR Research, Vol 2012 (2012)
Chagas disease, which is caused by Trypanosoma cruzi (T. cruzi), remains a substantial public health concern and an important cause of morbidity and mortality in Latin America. T. cruzi infection causes an intense inflammatory response in diverse tis
Externí odkaz:
https://doaj.org/article/94e9d102929e4dada87ef7b8e0bca28f
Autor:
Cristina S. Rigazio, Nilo Mariz-Ponte, Eugenia Pérez Caballero, Federico N. Penas, Nora B. Goren, Miguel H. Santamaría, Ricardo S. Corral
Publikováno v:
Microbial pathogenesis. 173
Cardiomyopathy is the most serious complication of chronic Chagas disease, caused by infection with the protozoan Trypanosoma cruzi. Exacerbated inflammation of the myocardium constitutes a major pathologic component of the disease. In the myocardial
Publikováno v:
Clinical Immunology. 101:86-93
The non-obese diabetic (NOD) mouse model of autoimmune sialadenitis offers the possibility of studying the L-arginine/nitric oxide signaling pathway in salivary glands in basal and neurotransmitter-stimulated conditions and, thus, of analyzing the ne
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79445 (2013)
Trypanosoma cruzi (T. cruzi) infection produces an intense inflammatory response which is critical for the control of the evolution of Chagas' disease. Interleukin (IL)-10 is one of the most important anti-inflammatory cytokines identified as modulat
Externí odkaz:
https://doaj.org/article/56830f13df4b4c7d85cc81dea1841789